Antibe Therapeutics Inc.

TSE: CA:ATE

GO

ATE
/zigman2/quotes/203044618/delayed

$

0.69

Change

+0.02 +2.99%

Volume

Volume 13,869

May 24, 2022, 3:53 p.m.

Quotes are delayed by 15 min

/zigman2/quotes/203044618/delayed

Previous close

$ 0.67

$ 0.69

Change

+0.02 +2.99%

Day low

Day high

$0.66

$0.69

Open
Open: 0.68

52 week low

52 week high

$0.64

$4.22

Open

Market cap

$34.75M

Average volume

26,622

P/E ratio

N/A

Rev. per Employee

$210,259

EPS

-0.53

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/ca/ate

MarketWatch News on ATE

No News currently available for ATE

/news/nonmarketwatch/company/ca/ate

Other News on ATE

/news/pressrelease/company/ca/ate

Press Releases on ATE

  1. Antibe Therapeutics Announces Results of 2021 Annual Meeting

    5:30 p.m. Aug. 19, 2021

    - BusinessWire - BZX

  2. Antibe Therapeutics Provides Clinical Update for Otenaproxesul

    7:00 a.m. Aug. 3, 2021

    - BusinessWire - BZX

  3. This Could Massively Disrupt the $24.35 Billion NSAID Market

    9:43 a.m. June 25, 2021

    - Baystreet.ca

Rates »

Link to MarketWatch's Slice.